NCT04831047View on ClinicalTrials.gov

The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

June 8, 2021

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2022

Conditions
Ptosis, EyelidConjunctiva InflamedEye Manifestations
Interventions
DRUG

Oxymetazoline hydrochloride 0.1% ophthalmic solution

One drop of Upneeq (Oxymetazoline hydrochloride 0.1% ophthalmic solution) will be applied to the ocular surface of each eye.

DRUG

Placebo

One drop of placebo (balanced saline solution) will be applied to the ocular surface of each eye.

Trial Locations (1)

33136

University of Miami Bascom Palmer Eye Institute, Miami

All Listed Sponsors
lead

University of Miami

OTHER